KD | Control | p-value | |
---|---|---|---|
aFunctioning | |||
Future perspective | |||
Week 0 | 66 (33–100) | 66 (33–66) | 0/60 |
Week 12 | 66 (33–66) | 33 (33–100) | 0/85 |
p-value | 0/45 | 0/76 | |
bSymptoms+ | |||
Arm | |||
Week 0 | 11 (0–36) | 11 (0–22) | 0/36 |
Week 12 | 11 (0–36) | 22 (0–33) | 88 |
p-value | 0/70 | 0/59 | |
Breast | |||
Week 0 | 8 (0–33) | 8 (0–25) | 0/34 |
Week 12 | 8 (0–10) | 8 (0–16) | 0/55 |
p-value | 0/01 | 0/34 | |
Systemic therapy side effects | |||
Week 0 | 9 (4–17) | 14 (4–23) | 0/54 |
Week 12 | 42 (20–52) | 42 (33–52) | 0/33 |
p-value | 0</001 | 0</001 | |
Concerns over hair loss | |||
Week 0 | 0 | 0 | 0/20 |
Week 12 | 66 (33–100) | 33 (33–100) | 0/50 |
p-value | 0</001 | 0</001 |